The United States Food and Drug Administration (US FDA) has approved VYKAT™ XR, a significant milestone as the first approved treatment for hyperphagia in Prader-Willi syndrome (PWS).

Research from Weill Cornell Medicine has identified a molecular pathway linking omega-6 linoleic acid—a common dietary fat in ...

Lilly's drug is one of several being tested to treat high Lp(a), a risk factor for heart disease that affects an estimated ...

Since 2000, when the FDA approved recombinant human growth hormone (rhGH) for those with the rare genetic disorder ...

Spending growth for simple medications used to treat common health problems is outstripping spending growth for pricey medications used to treat complex and chronic conditions, according to a new ...

Spending growth for traditional drugs — simple-to-administer medications ... are a class of drugs that work by mimicking a hormone that regulates blood sugar levels. GLP-1s have been approved ...

Researchers noticed that some patients taking it experienced increased hair growth as a side effect. Rogaine was approved by the Food and Drug Administration in 1988, the first drug to win the ...

Further research revealed that one of these drugs, DDL-920 – developed at UCLA, led to the complete recovery of movement control – something many stroke patients never regain.

The company says that Telomir-1 actively suppresses cancer growth and protects against chemotherapy ... tumor development…We are seeing a drug that extends cellular health while simultaneously ...

Growth hormones help to: HGH therapy works to supplement or replace the body's natural growth hormone. You might receive HGH therapy for any of these Food and Drug Administration (FDA)–approved ...

With that in mind, I say thank you to the menopause warriors for bringing public attention to the benefits of these hormone drugs in circumstances where the medical fraternity remains risk-averse ...